Clinical Trial Update: Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing the effects of Bydureon on re-endothelialisation in type 2 diabetes patients with atherosclerosis/rest restenosis histor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Diabetes
• Restenosis

Drugs mentioned

• Bydureon (exenatide)

Snippet

Sponsor: Karolinska Institutet | Conditions: Atherosclerosis, Diabetes | Phase 4 | Status: COMPLETED